Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wegro_app Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1787088114588209152.png) Wegro App [@wegro_app](/creator/twitter/wegro_app) on x 10.3K followers
Created: 2025-07-16 10:12:10 UTC

Lupin Ltd. announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. This ophthalmic suspension is bioequivalent to Lotemaxยฎ Ophthalmic Suspension, 0.5%, from Bausch & Lomb Inc. ๐Ÿ’Š It's indicated for steroid-responsive inflammatory conditions & post-operative inflammation. Estimated annual sales of the reference product were USD XX million. ๐Ÿ‡บ๐Ÿ‡ธ

- ๐—ฃ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐˜€:
  โ–ช Loteprednol Etabonate Ophthalmic Suspension, XXX% is now available in the US market.
  โ–ช It is a generic version of Lotemaxยฎ Ophthalmic Suspension, 0.5%.
  โ–ช The drug is designed to treat various inflammatory conditions of the eye.

- ๐—œ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€:
  โ–ช Allergic conjunctivitis.
  โ–ช Acne rosacea.
  โ–ช Superficial punctate keratitis.
  โ–ช Herpes zoster keratitis.
  โ–ช Iritis and cyclitis.
  โ–ช Selected infective conjunctivitides.
  โ–ช Post-operative inflammation following ocular surgery.

- ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐——๐—ฎ๐˜๐—ฎ:
  โ–ช The reference product, Lotemaxยฎ, had estimated annual sales of USD XX million in the U.S. (IQVIA MAT May 2025). ๐Ÿ’ฐ

- ๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—Ÿ๐˜‚๐—ฝ๐—ถ๐—ป:
  โ–ช Lupin is a global pharma company headquartered in Mumbai, India.
  โ–ช It operates in over XXX markets.
  โ–ช Lupin's product range includes branded & generic formulations, complex generics, biotech products, and APIs.
  โ–ช The company has a strong presence in India and the U.S. across multiple therapeutic areas.
  โ–ช Lupin has XX manufacturing sites and X research centers globally.
  โ–ช The company employs over XXXXXX professionals.

- ๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜:
  โ–ช Rajalakshmi Azariah, VP & Global Head โ€“ Corporate Communications, Lupin. ๐Ÿ“ง

๐Ÿ“Š LUPIN LTD | ๐Ÿท๏ธ Press Release / Media Release

๐ŸŒ Details:

โšก๏ธAI-driven WhatsApp updates - Try FREE ๐Ÿ‘‰


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945426224030879890/c:line.svg)

**Related Topics**
[united states dollar](/topic/united-states-dollar)
[united states](/topic/united-states)
[$blco](/topic/$blco)

[Post Link](https://x.com/wegro_app/status/1945426224030879890)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

wegro_app Avatar Wegro App @wegro_app on x 10.3K followers Created: 2025-07-16 10:12:10 UTC

Lupin Ltd. announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. This ophthalmic suspension is bioequivalent to Lotemaxยฎ Ophthalmic Suspension, 0.5%, from Bausch & Lomb Inc. ๐Ÿ’Š It's indicated for steroid-responsive inflammatory conditions & post-operative inflammation. Estimated annual sales of the reference product were USD XX million. ๐Ÿ‡บ๐Ÿ‡ธ

  • ๐—ฃ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐˜€: โ–ช Loteprednol Etabonate Ophthalmic Suspension, XXX% is now available in the US market. โ–ช It is a generic version of Lotemaxยฎ Ophthalmic Suspension, 0.5%. โ–ช The drug is designed to treat various inflammatory conditions of the eye.

  • ๐—œ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€: โ–ช Allergic conjunctivitis. โ–ช Acne rosacea. โ–ช Superficial punctate keratitis. โ–ช Herpes zoster keratitis. โ–ช Iritis and cyclitis. โ–ช Selected infective conjunctivitides. โ–ช Post-operative inflammation following ocular surgery.

  • ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐——๐—ฎ๐˜๐—ฎ: โ–ช The reference product, Lotemaxยฎ, had estimated annual sales of USD XX million in the U.S. (IQVIA MAT May 2025). ๐Ÿ’ฐ

  • ๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—Ÿ๐˜‚๐—ฝ๐—ถ๐—ป: โ–ช Lupin is a global pharma company headquartered in Mumbai, India. โ–ช It operates in over XXX markets. โ–ช Lupin's product range includes branded & generic formulations, complex generics, biotech products, and APIs. โ–ช The company has a strong presence in India and the U.S. across multiple therapeutic areas. โ–ช Lupin has XX manufacturing sites and X research centers globally. โ–ช The company employs over XXXXXX professionals.

  • ๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜: โ–ช Rajalakshmi Azariah, VP & Global Head โ€“ Corporate Communications, Lupin. ๐Ÿ“ง

๐Ÿ“Š LUPIN LTD | ๐Ÿท๏ธ Press Release / Media Release

๐ŸŒ Details:

โšก๏ธAI-driven WhatsApp updates - Try FREE ๐Ÿ‘‰

XX engagements

Engagements Line Chart

Related Topics united states dollar united states $blco

Post Link

post/tweet::1945426224030879890
/post/tweet::1945426224030879890